SCULPTRA
- Correcting Lipoatrophy
Sculptra® is an enduring treatment approved by the FDA for
restoration and/or correction of the signs of facial fat loss,
or lipoatrophy. It is the first FDA-approved product of its kind
for this condition.
Facial fat loss, or lipoatrophy,
is the loss of fat beneath the skin, which can result in sunken
cheeks, indentations, and hollow eyes. Sculptra® is a safe,
synthetic, and biocompatible material that is injected below the
surface of the skin in the area of fat loss.
It provides a gradual and significant
increase in skin thickness, improving the appearance of folds and
sunken areas over several months. 2-4 treatment sessions are required
to obtain optimal results. No skin testing is required.
Sculptra® has been safely
used outside the United States since 1999 in over 150,000 patients.